81 Results for "

neuropathic pain model

" in MedChemExpress (MCE) Product Catalog:
Products (81)

81 Results for "neuropathic pain model" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-101513
CAS No.: 2095486-67-0
Purity:  99.96%
eIF4A3-IN-1 is a selective eIF4A3 inhibitor (IC50: 0.26 μM; Kd: 0.043 μM) with cellular nonsense-mediated RNA decay (NMD) inhibitory activity. eIF4A3-IN-1 can specifically bind to the non-ATP binding site of eIF4A3. eIF4A3-IN-1 has anti-tumor and analgesic activities .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-11079
CAS No.: 944261-79-4
Purity:  99.09%
A-803467 is a potent and selective tetrodotoxin-resistant Nav1.8 sodium channel blocker (IC50=8 nM). A-803467 has shown significant anti-nociception in neuropathic and inflammatory pain models. A-803467 enhances the chemosensitivity of conventional anticancer agents through interaction with the ATP-binding cassette subfamily G member 2 (ABCG2) transporter .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18099
CAS No.: 878141-96-9
Synonyms: E-52862
Research Areas:  

Neurological Disease

S1RA (E-52862) is a highly selective σ1 receptor (σ1R) antagonist with Kis of 17 nM and 23.5 nM for human σ1R and guinea pig σ1R, respectively. S1RA has Moderate antagonistic activity for human 5-HT2B receptor (Ki= 328 nM). S1RA has antinociceptive effects in neuropathic pain models. S1RA prevents mechanical and cold hypersensitivity in Oxaliplatin (HY-17371)-treated mice .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1279
CAS No.: 5907-38-0
Synonyms: Dipyrone hydrate; Methamizole sodium hydrate
Target:  

COX Apoptosis

Research Areas:  

Inflammation/Immunology

Metamizole sodium hydrate (Dipyrone) is an orally active cyclooxygenase (COX) inhibitor.. Metamizole sodium hydrate can inhibit cell proliferation and promote cell apoptosis. Metamizole sodium hydrate has anti-inflammatory and antioxidant activities. Metamizole sodium hydrate is an antipyretic, analgesic and spasmolytic agent. Metamizole sodium hydrate can be used in research to relieve a variety of pain .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15451
CAS No.: 1048973-47-2
Purity:  99.26%
Synonyms: BZO-HEXOXIZID
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1279A
CAS No.: 68-89-3
Synonyms: Dipyrone; Methamizole sodium
Target:  

COX Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Metamizole sodium (Dipyrone) is an orally active cyclooxygenase (COX) inhibitor. Metamizole sodium can inhibit cell proliferation and promote cell apoptosis. Metamizole sodium has anti-inflammatory and antioxidant activities. Metamizole sodium is an antipyretic, analgesic and spasmolytic agent. .Metamizole sodium can be used in research to relieve a variety of pain .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13954
CAS No.: 870061-27-1
Purity:  98.08%
A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockade are mediated by blocking the release of IL-1beta .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120380
CAS No.: 133314-07-5
Purity:  99.8%
Target:  

MOFs PARP

Research Areas:  

Neurological Disease

FeTMPyP is an orally active poly (ADP-ribose) polymerase (PARP) inhibitor. FeTMPyP inhibits cell death, nitrotyrosine formation, and depolarization of mitochondrial transmembrane potential. FeTMPyP reduces homocysteine-induced nitrosative stress and partially restores TFEB protein and mRNA levels. FeTMPyP improves functional and behavioral deficits caused by chronic constriction injury in rats. FeTMPyP alleviates acute cerebral infarction in a rat model of middle cerebral artery occlusion with mild hyperglycemia. FeTMPyP can be used in studies related to neuropathic pain, renal aging, ischemic penumbra, and hyperglycemic stroke .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133130
CAS No.: 1252765-13-1
Purity:  99.42%
Target:  

MAGL

Research Areas:  

Neurological Disease

JNJ-42226314, a chemical probe, is a competitive, highly selective and reversible non-covalent monoacylglycerol lipase (MAGL) inhibitor. JNJ-42226314 demonstrates dose-dependent enhancement of the major endocannabinoid 2-arachidonoylglycerol (2-AG) as well as efficacy in models of neuropathic and inflammatory pain .
loading...
    loading...
Cat. No.: HY-17444
CAS No.: 251565-85-2
Target:  

PPAR

Research Areas:  

Metabolic Disease Cancer

Tesaglitazar is a dual-target PPARα/γ agonist with an EC50 of 13.4 μM for rat PPARα and 3.6 μM for human PPARα. Tesaglitazar affects lipid and glucose metabolism by activating PPARα and PPARγ receptors, and has the potential to improve blood sugar and relieve pain. Tesaglitazar can be used to induce in vivo tumor models and can be used in the study of type 2 diabetes, dyslipidemia, and neuropathic pain .
loading...
    loading...
Cat. No.: HY-156815
CAS No.: 3077715-58-0
Purity:  99.96%
Target:  

Orphan GPCR

YL-365 is a potent and selective GPR34 antagonist with an IC50 of 17 nM. YL-365 binds to a portion of the orthosteric binding pocket of GPR34 and induces allosteric changes that stabilize the receptor in an inactive conformation. YL-365 down-regulates expression of the proinflammatory gene iNOS in M1 microglia and suppresses proinflammatory responses. YL-365 reduces mechanical allodynia in a dose-dependent manner in a mouse model of neuropathic pain. YL-365 can be used for the research of neuropathic pain .
loading...
    loading...
Cat. No.: HY-N6967
CAS No.: 23089-26-1
Synonyms: (-)-α-Bisabolol
Levomenol ((-)-α-Bisabolol), a monocyclic sesquiterpene alcohol, exerts antioxidant, anti-inflammatory, and anti-apoptotic activities. Levomenol also has neuroprotective effects and prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice. Levomenol attenuates nociceptive behaviour and central sensitisation in a rodent model of trigeminal neuropathic pain. Orally active .
loading...
    loading...
Cat. No.: HY-A0042
CAS No.: 106308-44-5
Synonyms: CGP 33101; E 2080; RUF 331
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na + current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome .
loading...
    loading...
Cat. No.: HY-139347
CAS No.: 1638588-92-7
Purity:  99.09%
Synonyms: LY3556050; CNTX-0290
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

Mazisotine (CNTX-0290) is an orally active, non-opioid somatostatin receptor 4 (SSTR4) agonist with an EC50 of 4.7 nM. Mazisotine exerts significant analgesic effects in various nociceptive (inflammatory, osteoarthritic) and neuropathic pain models. Mazisotine can be used for pain research .
loading...
    loading...
Cat. No.: HY-N3710
CAS No.: 65236-62-6
Synonyms: Kumujian G; O-Methylpicrasidine I
Dehydrocrenatidine, a natural alkaloid, is a specific JAK inhibitor. Dehydrocrenatidine inhibits voltage-gated sodium channels and ameliorates mechanic allodia in a rat model of neuropathic pain .
loading...
    loading...
Cat. No.: HY-19636
CAS No.: 1346528-50-4
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

JNJ-42165279 is an orally active FAAH inhibitor, with IC50 values of 70 nM for hFAAH and 313 nM for rFAAH. JNJ-42165279 can be used in research related to the field of neuropathic pain .
loading...
    loading...
Cat. No.: HY-155417
CAS No.: 3049949-94-9
Purity:  99.88%
Target:  

Orphan GPCR ERK

Research Areas:  

Neurological Disease

GPR34 receptor antagonist 3 (Compound 5e) is a class of GRP34 antagonists, IC50 is 0.680 μM. GPR34 receptor antagonist 3 inhibited ERK1/2 phosphorylation induced by lysophosphatidylserine in a dose-dependent way without obvious cytotoxicity. GPR34 receptor antagonist 3 shows antisensory activity in mouse neuropathic pain model .
loading...
    loading...
Cat. No.: HY-131004
CAS No.: 2244579-87-9
Purity:  98.46%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

CB2R PAM is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator. CB2R PAM displays antinociceptive activity in vivo in an experimental mouse model of neuropathic pain .
loading...
    loading...
Cat. No.: HY-178281
CAS No.: 931928-13-1
Research Areas:  

Neurological Disease

E0199 is a novel potent dual-target KV7/NaV modulator that activates the KV7 channel (KV7.2/7.3 (EC50 = 12.78 nM), KV7.2 (EC50 = 0.50 μM), and KV7.5 (EC50 = 27.14 nM) channels) while simultaneously blocks the NaV1.7 (IC50 = 0.52 μM), NaV1.8 (IC50 = 0.24 μM), and NaV1.9 (IC50 = 0.16 μM) channels. E0199 shows a potent analgesic effect without affecting heart and skeletal muscle ion channels critically in a chronic constriction injury (CCI) mouse model. E0199 can be used for Neuropathic pain (NP) research .
loading...
    loading...
Cat. No.: HY-111996
CAS No.: 1380696-64-9
Kv3 activator-1 is a Kv3 family voltage-gated potassium channel activator. Kv3 activator-1 reverses mechanical hyperalgesia in rat models of neuropathic and inflammatory pain, with rapid onset and long-lasting, dose-related effects. Kv3 activator-1 can be used for the research of pain .
loading...
    loading...